Tolcapone (Tasmar)
Robertson
S
S
D000978:Antiparkinson Agents / Q000009:adverse effects*; D001577:Benzophenones / Q000009:adverse effects*; D002170:Canada; D065098:Catechol O-Methyltransferase Inhibitors; D056486:Chemical and Drug Induced Liver Injury; D017277:Drug Approval; D006801:Humans; D009596:Nitrophenols; D000077867:Tolcapone
D000978:Antiparkinson Agents; D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D009596:Nitrophenols; D000077867:Tolcapone